ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Neurology

Top Neurology Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
YANCHUN ZHANG MD

Neurology

13,457

$1.85M

392
179 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 31%

$138
Average prescription price

Avg: $285

DHARAMSI SHAH M.D.

Neurology

7,658

$1.06M

343
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 31%

$138
Average prescription price

Avg: $285

ERIC GELLER M.D.

Neurology

6,117

$1.01M

328
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 31%

$165
Average prescription price

Avg: $285

YAN LUPYAN MD

Neurology

6,077

$926K

769
700 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 31%

$152
Average prescription price

Avg: $285

ALLEN RUBIN MD

Neurology

6,010

$867K

227
59 are 65+

24%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 31%

$144
Average prescription price

Avg: $285

NAGESH KRISH M.D., P.A.

Neurology

5,594

$1.06M

508
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

50%
prescriptions for brand name drugs

Avg: 31%

$189
Average prescription price

Avg: $285

THOMAS MIRSEN MD

Neurology

4,926

$1.4M

510
310 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 31%

$285
Average prescription price

Avg: $285

ROGER BEHAR M.D.

Neurology

4,570

$1.19M

507
431 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 31%

$261
Average prescription price

Avg: $285

ELIOT CHODOSH M.D.

Neurology

4,450

$738K

439
361 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 31%

$166
Average prescription price

Avg: $285

SYED JAFRI MD

Neurology

4,286

$595K

522
374 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 31%

$139
Average prescription price

Avg: $285

MARY ANN PICONE MD

Neurology

4,027

$5.51M

275
77 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 31%

$1369
Average prescription price

Avg: $285

GREGORY ANSELMI M.D.

Neurology

3,636

$729K

319
234 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 31%

$200
Average prescription price

Avg: $285

ANTWAN AHAD MD

Neurology

3,602

$760K

314
237 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 31%

$211
Average prescription price

Avg: $285

NALINI PRASAD

Neurology

3,591

$633K

457
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 31%

$176
Average prescription price

Avg: $285

LORETO LIZARDO M.D.

Neurology

3,298

$490K

149
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 31%

$149
Average prescription price

Avg: $285

AMOS KATZ MD

Neurology

3,255

$3.32M

317
159 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 31%

$1021
Average prescription price

Avg: $285

MAUREEN GOTTFRIED DO

Neurology

3,253

$900K

429
324 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 31%

$277
Average prescription price

Avg: $285

MATTHEW DELUCA MD

Neurology

3,203

$761K

345
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 31%

$238
Average prescription price

Avg: $285

KEVIN HUNTER MD

Neurology

3,140

$981K

438
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 31%

$312
Average prescription price

Avg: $285

KIRK LEVY MD

Neurology

3,042

$532K

347
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 31%

$175
Average prescription price

Avg: $285

FAROOQ REHMAN M.D.

Neurology

2,966

$599K

331
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 31%

$202
Average prescription price

Avg: $285

STEVE LEQUERICA MD

Neurology

2,943

$1.01M

325
229 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 31%

$344
Average prescription price

Avg: $285

JOSEPH HERBERT M.D.

Neurology

2,873

$4.32M

225
62 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 31%

$1503
Average prescription price

Avg: $285

PAUL GILSON M.D.

Neurology

2,844

$864K

328
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 31%

$304
Average prescription price

Avg: $285

STEVEN BROMLEY MD

Neurology

2,772

$1.19M

325
188 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 31%

$429
Average prescription price

Avg: $285

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank